Market News AIOpen the app

ALDX stock news · Aldeyra Therapeutics

Stories about Aldeyra Therapeutics (ALDX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ALDX

Follow Aldeyra Therapeutics (ALDX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ALDX
Free on the App Store and Google Play, or on the web.
  1. Oct 16, 2026, 5:18 PM ET · Market

    12 health care stocks changed a lot in prices during Friday's after-hours trading.

    Neutral

    Aldeyra Therapeutics shares rose 7.6% in Friday's after-market session. The roundup gives no business news that changes its outlook.

  2. Oct 6, 2026, 5:12 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Tuesday.

    Neutral

    Aldeyra Therapeutics shares rose about 7% after hours, but the article gives no company news. The share-price move alone does not change the company's outlook.

  3. Oct 5, 2026, 1:09 PM ET · Market

    12 health care stocks are changing a lot during Monday's trading.

    Neutral

    Aldeyra Therapeutics shares fell 22.06% during Monday’s session, but the story gives no reason or company update. The price move alone does not change its business outlook.

  4. Oct 5, 2026, 1:08 PM ET · Market

    12 health care companies saw big changes during Monday's trading.

    Neutral

    Aldeyra Therapeutics' shares fell 22% on Monday. The story gives no company news to show that its business prospects changed.

  5. Sep 29, 2026, 2:39 PM ET · Trial

    Aldeyra plans to challenge the FDA's rejection, causing its stock to jump 13.79%.

    Neutral

    Aldeyra plans to ask the FDA to review its reproxalap rejection, but the agency’s evidence concern remains. The request alone does not change the company’s outlook.